Rwanda vs Turkmenistan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Rwanda
0.3%
in 2024
Turkmenistan
0.3%
in 2024
Rwanda rank
67th
Turkmenistan rank
67th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Rwanda
- Turkmenistan
How they compare
Rwanda currently reports 0.3% against 0.3% in Turkmenistan, a difference of 0.0%.
Across all 10 years both countries report, Turkmenistan has been ahead every year.
Rwanda ranks 67th and Turkmenistan ranks 67th of 215 countries.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Rwanda | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | Turkmenistan |
| 2020s | 0.3% | 0.3% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Rwanda or Turkmenistan?
- Rwanda, at 0.3% against 0.3% in Turkmenistan as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Rwanda and Turkmenistan?
- 0.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Turkmenistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Rwanda and Turkmenistan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Rwanda ranks 67th and Turkmenistan ranks 67th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.